Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma

Abstract Background This retrospective study was to assess and compare the toxicity and efficacy of concurrent chemoradiotherapy (CCRT) with S-1 or docetaxel and cisplatin in patients with locally advanced esophageal squamous cell carcinoma (ESCC). Methods Patients with locally advanced ESCC who rec...

Full description

Bibliographic Details
Main Authors: Xi-Lei Zhou, Chang-Hua Yu, Wan-Wei Wang, Fu-Zhi Ji, Yao-Zu Xiong, Wei-Guo Zhu, Yu-Suo Tong
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Radiation Oncology
Subjects:
Esophageal cancer
Chemoradiotherapy
S-1
Docetaxel
Cisplatin
Online Access:https://doi.org/10.1186/s13014-021-01821-6

Similar Items

Similar Items